drugset
drugset / Trial / NCT00579436

Effects of Fish Oils on Inflammation and Insulin Resistance

NCT00579436 ↗

Completed 33 enrolled Philip Kern GlaxoSmithKline · collabNational Center for Research Resources (NCRR) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this study is to determine whether improvement in fat and muscle metabolism after the treatment with Omacor (fish oils) provides insight into the link between obesity, fat and muscle function leading to metabolic syndrome, which is a risk factor for heart disease and diabetes.

Timeline

Start
2007-01
Primary completion
2013-03-27
Completion
2015-01-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lovaza Other / unclassified 4 g Oral

Indications

metabolic syndrome X